Hill Stephen J. 4
4 · Lyell Immunopharma, Inc. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Hill Stephen J.
Chief Operating Officer
Transactions
- Sale
Common Stock
2025-11-10$16.12/sh−95$1,531→ 15,750 total
Footnotes (1)
- [F1]Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.